Treatment with the GnRH agonist (GnRHa) deslorelin (D) and low-dose add-back estradiol (E2) is effective in reducing pain, bleeding and uterine volume (UV) while maintaining bone mineral density (BMD) in women with symptomatic uterine fibroids (UF)
AnnaMarie Daniels, Malcolm C Pike, John R Daniels, Darcy V SpicerТом:
78
Рік:
2002
Мова:
english
DOI:
10.1016/s0015-0282(02)03551-3
Файл:
PDF, 28 KB
english, 2002